{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:03:24Z","timestamp":1788537804691,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1245\/s10434-026-19954-x","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:18:47Z","timestamp":1781612327000},"page":"7979-7988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combined Impact of Sarcopenia and Low Visceral Adiposity on Postoperative Outcomes and Survival After Esophagectomy for Esophageal Cancer"],"prefix":"10.1245","volume":"33","author":[{"given":"Taro","family":"Goda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Hayata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Kitadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinta","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"19954_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cac2.12645","volume":"45","author":"W Jiang","year":"2025","unstructured":"Jiang W, Zhang B, Xu J, Xue L, Wang L. Current status and perspectives of esophageal cancer: a comprehensive review. Cancer Commun (Lond). 2025;45:281\u2013331.","journal-title":"Cancer Commun (Lond)."},{"key":"19954_CR2","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/SLA.0000000000002398","volume":"266","author":"JA Elliott","year":"2017","unstructured":"Elliott JA, Doyle SL, Murphy CF, et al. Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg. 2017;266:822\u201330.","journal-title":"Ann Surg."},{"key":"19954_CR3","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1097\/SLA.0000000000002252","volume":"267","author":"Y Nakashima","year":"2018","unstructured":"Nakashima Y, Saeki H, Nakanishi R, et al. Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer. Ann Surg. 2018;267:1100\u20134.","journal-title":"Ann Surg."},{"key":"19954_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ejso.2016.11.015","volume":"43","author":"M Paireder","year":"2017","unstructured":"Paireder M, Asari R, Kristo I, et al. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. Eur J Surg Oncol. 2017;43:478\u201384.","journal-title":"Eur J Surg Oncol."},{"key":"19954_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/SLA.0000000000002679","volume":"268","author":"C Simonsen","year":"2018","unstructured":"Simonsen C, de Heer P, Bjerre ED, et al. Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology: A meta-analysis. Ann Surg. 2018;268:58\u201369.","journal-title":"Ann Surg."},{"key":"19954_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629\u201335.","journal-title":"Lancet Oncol."},{"key":"19954_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395.","journal-title":"Lancet Oncol."},{"key":"19954_CR8","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","volume":"15","author":"CM Prado","year":"2009","unstructured":"Prado CM, Baracos VE, McCargar LJ, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009;15:2920\u20136.","journal-title":"Clin Cancer Res."},{"key":"19954_CR9","first-page":"362","volume":"67","author":"CG Ethun","year":"2017","unstructured":"Ethun CG, Bilen MA, Jani AB, Maithel SK, Ogan K, Master VA. Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology. CA Cancer J Clin. 2017;67:362\u201377.","journal-title":"CA Cancer J Clin."},{"key":"19954_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cell.2015.02.022","volume":"161","author":"JR Brestoff","year":"2015","unstructured":"Brestoff JR, Artis D. Immune regulation of metabolic homeostasis in health and disease. Cell. 2015;161:146\u201360.","journal-title":"Cell."},{"key":"19954_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41423-021-00804-7","volume":"19","author":"K Man","year":"2022","unstructured":"Man K, Kallies A, Vasanthakumar A. Resident and migratory adipose immune cells control systemic metabolism and thermogenesis. Cell Mol Immunol. 2022;19:421\u201331.","journal-title":"Cell Mol Immunol."},{"key":"19954_CR12","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1245\/s10434-017-6077-y","volume":"24","author":"S Okumura","year":"2017","unstructured":"Okumura S, Kaido T, Hamaguchi Y, et al. Visceral adiposity and sarcopenic visceral obesity are associated with poor prognosis after resection of pancreatic cancer. Ann Surg Oncol. 2017;24:3732\u201340.","journal-title":"Ann Surg Oncol."},{"key":"19954_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ciresp.2024.08.004","volume":"103","author":"LD Juez","year":"2025","unstructured":"Juez LD, Ortega ADC, Priego P, Garc\u00eda P\u00e9rez JC, Fern\u00e1ndez-Cebri\u00e1n JM, Botella-Carretero JI. Impact of sarcopenic obesity on surgical complications and oncologic outcomes of upper gastrointestinal tumors: a systematic review and meta-analysis. Cir Esp (Engl Ed). 2025;103:182\u201394.","journal-title":"Cir Esp (Engl Ed)."},{"key":"19954_CR14","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.clnu.2022.05.002","volume":"41","author":"T Uchida","year":"2022","unstructured":"Uchida T, Sekine R, Matsuo K, Kigawa G, Umemoto T, Tanaka K. Impact of body fat and muscle quantity on short- and long-term outcome after gastrectomy for cancer. Clin Nutr. 2022;41:1467\u201374.","journal-title":"Clin Nutr."},{"key":"19954_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3892\/ol.2024.14233","volume":"27","author":"L Zuo","year":"2024","unstructured":"Zuo L, Lin J, Ge S, et al. Preoperative visceral fat index predicts the survival outcomes of patients with gastric cancer after surgery. Oncol Lett. 2024;27:99.","journal-title":"Oncol Lett."},{"key":"19954_CR16","first-page":"491","volume":"38","author":"Y Miyamoto","year":"2018","unstructured":"Miyamoto Y, Oki E, Emi Y, et al. Low visceral fat content is a negative predictive marker for bevacizumab in metastatic colorectal cancer. Anticancer Res. 2018;38:491\u20139.","journal-title":"Anticancer Res."},{"key":"19954_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2023.112302","volume":"118","author":"T Kamada","year":"2024","unstructured":"Kamada T, Ohdaira H, Takahashi J, et al. Effect of low visceral fat area on long-term survival of stage I-III colorectal cancer. Nutrition. 2024;118:112302.","journal-title":"Nutrition."},{"key":"19954_CR18","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.clnu.2021.04.019","volume":"40","author":"R Matsui","year":"2021","unstructured":"Matsui R, Inaki N, Tsuji T. Impact of visceral adipose tissue on compliance of adjuvant chemotherapy and relapse-free survival after gastrectomy for gastric cancer: a propensity score matching analysis. Clin Nutr. 2021;40:2745\u201353.","journal-title":"Clin Nutr."},{"key":"19954_CR19","first-page":"679","volume":"11","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s JM, Busquets S, Stemmler B, L\u00f3pez-Soriano FJ. Cancer cachexia: understanding the molecular basis to develop novel therapies. Nat Rev Clin Oncol. 2014;11:679\u201389.","journal-title":"Nat Rev Clin Oncol."},{"key":"19954_CR20","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer. TNM Classification of Malignant Tumors, Seventh Edition. Chichester, West Sussex, UK; Hoboken, NJ: Wiley-Blackwell, 2010."},{"key":"19954_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396.","journal-title":"Ann Surg."},{"key":"19954_CR22","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00330-015-3963-1","volume":"26","author":"D Tamandl","year":"2016","unstructured":"Tamandl D, Paireder M, Asari R, Baltzer PA, Schoppmann SF, Ba-Ssalamah A. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol. 2016;26:1359\u201367.","journal-title":"Eur Radiol."},{"key":"19954_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/sj.ijo.0800591","volume":"22","author":"RE Schoen","year":"1998","unstructured":"Schoen RE, Thaete FL, Sankey SS, Weissfeld JL, Kuller LH. Sagittal diameter in comparison with single slice CT as a predictor of total visceral adipose tissue volume. Int J Obes Relat Metab Disord. 1998;22:338\u201342.","journal-title":"Int J Obes Relat Metab Disord."},{"key":"19954_CR24","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1007\/s00595-025-03084-0","volume":"55","author":"T Goda","year":"2025","unstructured":"Goda T, Nakamura M, Hayata K, et al. Preoperative skeletal muscle density measured as an assessment of sarcopenia is correlated with postoperative complications in patients undergoing highly invasive surgery for upper abdominal cancer. Surg Today. 2025;55:1694\u2013700.","journal-title":"Surg Today."},{"key":"19954_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 Consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300-307.e2.","journal-title":"J Am Med Dir Assoc."},{"key":"19954_CR26","first-page":"163","volume":"57","author":"A Misra","year":"2009","unstructured":"Misra A, Chowbey P, Makkar BM, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163\u201370.","journal-title":"J Assoc Physicians India."},{"key":"19954_CR27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539\u201347.","journal-title":"J Clin Oncol."},{"key":"19954_CR28","doi-asserted-by":"publisher","first-page":"M326","DOI":"10.1093\/gerona\/57.5.M326","volume":"57","author":"M Visser","year":"2002","unstructured":"Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002;57:M326-332.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"19954_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40001-017-0266-9","volume":"22","author":"AL Bian","year":"2017","unstructured":"Bian AL, Hu HY, Rong YD, Wang J, Wang JX, Zhou XZ. A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-\u03b1. Eur J Med Res. 2017;22:25.","journal-title":"Eur J Med Res."},{"key":"19954_CR30","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/bjc.2012.350","volume":"107","author":"JR Lieffers","year":"2012","unstructured":"Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107:931\u20136.","journal-title":"Br J Cancer."},{"key":"19954_CR31","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1002\/cam4.3964","volume":"10","author":"O Nakano","year":"2021","unstructured":"Nakano O, Kawai H, Kobayashi T, et al. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer. Cancer Med. 2021;10:4291\u2013301.","journal-title":"Cancer Med."},{"key":"19954_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s13668-019-00280-6","volume":"8","author":"DH Lee","year":"2019","unstructured":"Lee DH, Giovannucci EL. The obesity paradox in cancer: epidemiologic insights and perspectives. Curr Nutr Rep. 2019;8:175\u201381.","journal-title":"Curr Nutr Rep."},{"key":"19954_CR33","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3945\/ajcn.113.071399","volume":"99","author":"MC Gonzalez","year":"2014","unstructured":"Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB. Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr. 2014;99:999\u20131005.","journal-title":"Am J Clin Nutr."},{"key":"19954_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/ajcn\/nqaa238","volume":"113","author":"C Martinez-Tapia","year":"2021","unstructured":"Martinez-Tapia C, Diot T, Oubaya N, et al. The obesity paradox for mid- and long-term mortality in older cancer patients: a prospective multicenter cohort study. Am J Clin Nutr. 2021;113:129\u201341.","journal-title":"Am J Clin Nutr."},{"key":"19954_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.28875","volume":"8","author":"C Canales","year":"2025","unstructured":"Canales C, Anderson M, Elashoff D, et al. Body mass index and postsurgical outcomes in older adults. JAMA Netw Open. 2025;8:e2528875.","journal-title":"JAMA Netw Open."},{"key":"19954_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ags3.12049","volume":"2","author":"M Ri","year":"2017","unstructured":"Ri M, Aikou S, Seto Y. Obesity as a surgical risk factor. Ann Gastroenterol Surg. 2017;2:13\u201321.","journal-title":"Ann Gastroenterol Surg."},{"key":"19954_CR37","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1245\/s10434-021-11321-2","volume":"29","author":"JF Shaw","year":"2022","unstructured":"Shaw JF, Budiansky D, Sharif F, McIsaac DI. The association of frailty with outcomes after cancer surgery: A systematic review and metaanalysis. Ann Surg Oncol. 2022;29:4690\u2013704.","journal-title":"Ann Surg Oncol."},{"key":"19954_CR38","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.1245\/s10434-024-15571-8","volume":"31","author":"S Lunca","year":"2024","unstructured":"Lunca S, Morarasu S, Rouet K, et al. Frailty increases morbidity and mortality in patients undergoing oncological liver resections: A systematic review and meta-analysis. Ann Surg Oncol. 2024;31:6514\u201325.","journal-title":"Ann Surg Oncol."},{"key":"19954_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70023","volume":"13","author":"Y Shen","year":"2024","unstructured":"Shen Y, Cong Z, Ge Q, et al. Effect of nutrition-based prehabilitation on the postoperative outcomes of patients with esophagogastric cancer undergoing surgery: a systematic review and meta-analysis. Cancer Med. 2024;13:e70023.","journal-title":"Cancer Med."},{"key":"19954_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11\u201348.","journal-title":"Clin Nutr."},{"key":"19954_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy AP, Currow DC, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016;17:519\u201331.","journal-title":"Lancet Oncol."},{"key":"19954_CR42","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3390\/cancers16091696","volume":"16","author":"S Pandey","year":"2024","unstructured":"Pandey S, Bradley L, Del Fabbro E. Updates in cancer cachexia: clinical management and pharmacologic interventions. Cancers (Basel). 2024;16:1696.","journal-title":"Cancers (Basel)."},{"key":"19954_CR43","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1136\/bmjspcare-2017-001440","volume":"8","author":"TS Solheim","year":"2018","unstructured":"Solheim TS, Laird BJ, Balstad TR, et al. Cancer cachexia: rationale for the MENAC (Multimodal\u2013Exercise, Nutrition and anti-inflammatory medication for cachexia) trial. BMJ Support Palliat Care. 2018;8:258\u201365.","journal-title":"BMJ Support Palliat Care."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19954-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19954-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19954-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T04:01:40Z","timestamp":1786248100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19954-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["19954"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19954-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The protocol was approved by the Ethics Committee of Wakayama Medical University. This trial was registered in the UMIN Clinical Trials Registry (UMIN000061751) and was conducted in accordance with the Declaration of Helsinki and the Ethical Guidelines for Clinical Studies issued by the Ministry of Health, Labor, and Welfare of Japan.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent was obtained from all participants through an opt-out approach approved by the institutional ethics committee. Detailed information about the study was publicly disclosed, and participants were provided the opportunity to decline participation.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}